Related Experiment Video
Updated: Nov 5, 2025

Author Spotlight: Advanced Single-Molecule Techniques for Investigating Telomeric Protein-DNA Interactions
Published on: August 30, 2024
Human telomerase is directly regulated by non-telomeric TRF2-G-quadruplex interaction
Shalu Sharma1, Ananda Kishore Mukherjee1, Shuvra Shekhar Roy1
1Integrative and Functional Biology Unit, CSIR-Institute of Genomics and Integrative Biology, New Delhi 110025, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India; CSIR-Institute of Genomics and Integrative Biology, New Delhi 110025, India.
Telomere-repeat-binding-factor 2 (TRF2) represses human telomerase reverse transcriptase (hTERT) by binding its promoter. This mechanism is disrupted in cancer, offering new therapeutic targets for aging and cancer.
Area of Science:
- Molecular Biology
- Cancer Biology
- Epigenetics
Background:
- Human telomerase reverse transcriptase (hTERT) is suppressed in normal cells, leading to telomere erosion and senescence.
- hTERT reactivation maintains telomeres and drives over 90% of cancers, but its regulation is not fully understood.
Purpose of the Study:
- To investigate the direct causal link between telomeres and telomerase regulation.
- To elucidate the mechanism by which TRF2 influences hTERT expression.
Main Methods:
- Chromatin immunoprecipitation assays to assess TRF2 binding to the hTERT promoter.
- Analysis of H3K27 trimethylation levels at the hTERT promoter.
- Investigating the impact of hTERT promoter mutations on TRF2 binding and hTERT expression.
- Utilizing ligand-induced G-quadruplex stabilization to restore TRF2 binding and hTERT suppression.
Main Results:
- TRF2 binds to G-quadruplexes in the hTERT promoter and recruits EZH2/PRC2.
- This binding causes H3K27 trimethylation, repressing hTERT in both normal and cancer cells.
- Recurrent hTERT promoter mutations destabilize G-quadruplexes, impairing TRF2 binding in glioblastoma.
- Stabilizing G-quadruplexes restored TRF2 binding, H3K27 trimethylation, and hTERT re-suppression.
Conclusions:
- A novel mechanism linking telomere factor TRF2 to hTERT repression via epigenetic modification (H3K27 trimethylation) is uncovered.
- This pathway is crucial for maintaining hTERT suppression and is disrupted in cancer.
- Targeting this telomere-telomerase axis holds potential for cancer therapy, aging interventions, and regenerative medicine.
Related Concept Videos
Telomeres and Telomerase
Telomeres and Telomerase
Replication in Eukaryotes
Replication in Eukaryotes
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
Replicative Cell Senescence
Transcription Elongation Factors
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...

